Additional Study Information: This is a prospective, multi-center, single-arm study aimed at finding out if the clinical performance of a device called the Orsiro stent, in a real-world setting is similar to the clinical performance observed for the device in the BIOFLOW-V IDE pivotal trial. After receiving the Orsiro stent, you will be followed through 5 years of follow-up, with assessments performed at 1 month, 1 year and annually thereafter. All visits will be performed by telephone interview, unless a standard of care routine office visit is planned within the applicable follow-up window.